Key result
The HeartFull integrated care program for advanced heart failure was feasible, with 70% of deaths occurring in non-acute settings and no significant change in hospitalizations (RR 0.715; 95% CI 0.360-1.388; P=0.318).
Why the study?
Patients with advanced heart failure face high mortality and healthcare utilization alongside low palliative care involvement.
Does an integrated cardiology and palliative care program improve end-of-life care settings and reduce healthcare utilization in patients with advanced heart failure?
Observational (n=30)
No
Does an integrated cardiology and palliative care program improve end-of-life care settings and reduce healthcare utilization in patients with advanced heart failure?
An integrated cardiology and palliative care program for advanced heart failure is feasible and associated with a high rate of death in non-acute care settings.
HeartFull integrated palliative care appears feasible in advanced HF; leaves open efficacy and outcomes in randomized trials.
Introduction: Patients at an advanced stage of heart failure (AHF), specifically chronic severe symptomatic heart failure defined as New York Heart Association III/IV with hospitalization in the year prior, have high mortality, healthcare utilization, and low palliative care involvement. Objectives: The primary objectives were to determine the feasibility of recruiting patients and engaging cardiology and palliative healthcare providers in a program of integrated care for AHF (HeartFull); the proportion of patients who died in non-acute care settings. Secondary objectives were to describe patient-reported outcomes and pre-post comparison of healthcare utilization. Methods: Patients were recruited from an urban academic hospital with expert heart failure care and a 24/7 inpatient and home palliative service. Utilization, disposition, and surveys were collected monthly for up to 20 months. Results: Of 46 patients referred, 30 (65%) agreed to participate, 27 died during the study period, 19 (70%) died in non-acute care settings, while 8 (30%) died in hospital. We found no significant difference in pre- and post-intervention rates of hospitalization (RR .715; CI .360, 1.388; P = .3180), nor emergency visits (RR .678; CI .333, 1.338; P = .2590), but both trended downward. No significant changes were observed in patient-reported outcomes. Conclusion: In an urban academic hospital with palliative care, it was feasible to implement an integrated program for AHF. Patients died at home or in a palliative care unit at rates similar to palliative oncology patients and at higher rates than the general AHF population. HeartFull is now part of clinical practice.
No takes yet. Share an insight, caveat, or question.
Steinberg et al. (2022) conducted an observational in Advanced stage of heart failure (n=30). HeartFull integrated program of care vs. Pre-intervention was evaluated on Feasibility of recruiting patients and engaging providers, and proportion of patients who died in non-acute care settings. The HeartFull integrated care program for advanced heart failure was feasible, with 70% of deaths occurring in non-acute settings and no significant change in hospitalizations (RR 0.715; 95% CI 0.360-1.388; P=0.318).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: